Free Trial

Flora Growth (FLGC) Competitors

Flora Growth logo
$24.01 +0.21 (+0.90%)
Closing price 03:58 PM Eastern
Extended Trading
$24.22 +0.21 (+0.88%)
As of 07:13 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

FLGC vs. INMB, BRNS, ATNM, FGEN, TPST, VRCA, LTRN, PEPG, NBRV, and RNXT

Should you be buying Flora Growth stock or one of its competitors? The main competitors of Flora Growth include INmune Bio (INMB), Barinthus Biotherapeutics (BRNS), Actinium Pharmaceuticals (ATNM), FibroGen (FGEN), Tempest Therapeutics (TPST), Verrica Pharmaceuticals (VRCA), Lantern Pharma (LTRN), PepGen (PEPG), Nabriva Therapeutics (NBRV), and RenovoRx (RNXT). These companies are all part of the "pharmaceutical products" industry.

Flora Growth vs. Its Competitors

Flora Growth (NASDAQ:FLGC) and INmune Bio (NASDAQ:INMB) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, dividends, risk, valuation, analyst recommendations, profitability, media sentiment and earnings.

INmune Bio has a net margin of 0.00% compared to Flora Growth's net margin of -24.86%. INmune Bio's return on equity of -120.62% beat Flora Growth's return on equity.

Company Net Margins Return on Equity Return on Assets
Flora Growth-24.86% -261.57% -48.06%
INmune Bio N/A -120.62%-92.94%

In the previous week, Flora Growth and Flora Growth both had 2 articles in the media. Flora Growth's average media sentiment score of 1.46 beat INmune Bio's score of 0.64 indicating that Flora Growth is being referred to more favorably in the media.

Company Overall Sentiment
Flora Growth Positive
INmune Bio Positive

Flora Growth has higher revenue and earnings than INmune Bio. INmune Bio is trading at a lower price-to-earnings ratio than Flora Growth, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Flora Growth$59.51M0.23-$15.91M-$34.38-0.70
INmune Bio$10K5,342.58-$42.08M-$2.48-0.81

36.0% of Flora Growth shares are owned by institutional investors. Comparatively, 12.7% of INmune Bio shares are owned by institutional investors. 12.6% of Flora Growth shares are owned by company insiders. Comparatively, 35.7% of INmune Bio shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Flora Growth has a beta of 1.97, indicating that its share price is 97% more volatile than the S&P 500. Comparatively, INmune Bio has a beta of 1.03, indicating that its share price is 3% more volatile than the S&P 500.

Flora Growth currently has a consensus price target of $93.00, indicating a potential upside of 287.27%. INmune Bio has a consensus price target of $18.40, indicating a potential upside of 815.42%. Given INmune Bio's higher possible upside, analysts clearly believe INmune Bio is more favorable than Flora Growth.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Flora Growth
0 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
3.00
INmune Bio
1 Sell rating(s)
2 Hold rating(s)
3 Buy rating(s)
1 Strong Buy rating(s)
2.57

Summary

INmune Bio beats Flora Growth on 8 of the 15 factors compared between the two stocks.

Get Flora Growth News Delivered to You Automatically

Sign up to receive the latest news and ratings for FLGC and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding FLGC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

FLGC vs. The Competition

MetricFlora GrowthMED PRODUCTS IndustryMedical SectorNASDAQ Exchange
Market Cap$13.77M$10.65B$5.79B$10.15B
Dividend YieldN/A1.85%5.69%4.61%
P/E RatioN/A21.1374.5925.92
Price / Sales0.2331.03449.5483.33
Price / CashN/A24.7237.0859.91
Price / Book1.973.5212.156.29
Net Income-$15.91M$210.50M$3.28B$270.85M
7 Day Performance6.23%-0.18%0.98%3.36%
1 Month Performance31.87%3.91%7.20%6.41%
1 Year Performance-33.79%-10.02%63.06%28.26%

Flora Growth Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
FLGC
Flora Growth
3.2741 of 5 stars
$24.01
+0.9%
$93.00
+287.3%
-35.5%$13.77M$59.51M0.00280Positive News
Short Interest ↓
Gap Up
INMB
INmune Bio
2.9762 of 5 stars
$1.81
-7.2%
$18.40
+916.6%
-68.4%$51.84M$10K-0.7310Positive News
Short Interest ↓
BRNS
Barinthus Biotherapeutics
2.9869 of 5 stars
$1.22
-2.0%
$3.00
+146.9%
-4.6%$50.49M$14.97M-0.70107Positive News
Gap Up
ATNM
Actinium Pharmaceuticals
3.062 of 5 stars
$1.60
+1.3%
$4.50
+181.3%
-13.8%$49.91MN/A-1.1530Positive News
Short Interest ↑
FGEN
FibroGen
4.5144 of 5 stars
$11.16
-7.8%
$43.00
+285.3%
+25.4%$48.93M$29.62M-29.37570News Coverage
TPST
Tempest Therapeutics
2.4519 of 5 stars
$10.85
-1.3%
$30.00
+176.5%
-40.3%$48.80MN/A-0.7420Positive News
VRCA
Verrica Pharmaceuticals
4.0846 of 5 stars
$5.06
-1.0%
$80.00
+1,481.0%
-74.4%$48.22M$7.57M-0.6140Positive News
LTRN
Lantern Pharma
2.6122 of 5 stars
$4.06
-5.8%
$25.00
+515.8%
+5.6%$46.54MN/A-2.2820
PEPG
PepGen
2.8258 of 5 stars
$1.49
+6.4%
$7.67
+414.5%
-85.0%$45.92MN/A-0.5030Analyst Forecast
Gap Up
NBRV
Nabriva Therapeutics
N/AN/AN/AN/A$45.46M$35.59M0.0070
RNXT
RenovoRx
2.3516 of 5 stars
$1.14
-8.1%
$7.50
+557.9%
+18.0%$45.44M$40K-3.006News Coverage
Short Interest ↑
Gap Up

Related Companies and Tools


This page (NASDAQ:FLGC) was last updated on 9/12/2025 by MarketBeat.com Staff
From Our Partners